• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本多发性肌炎和皮肌炎的患病率与发病率。

Prevalence and incidence of polymyositis and dermatomyositis in Japan.

作者信息

Ohta Akiko, Nagai Masaki, Nishina Motoko, Tomimitsu Hiroyuki, Kohsaka Hitoshi

机构信息

Department of Public Health, Saitama Medical University Faculty of Medicine , Saitama , Japan.

出版信息

Mod Rheumatol. 2014 May;24(3):477-80. doi: 10.3109/14397595.2013.844308. Epub 2013 Oct 21.

DOI:10.3109/14397595.2013.844308
PMID:24252012
Abstract

OBJECTIVES

To estimate the number of patients with polymyositis/dermatomyositis (PM/DM) in Japan and the prevalence rate and incidence rate of the disease.

METHODS

The electronic database in the nationwide registration system on intractable diseases from 2003 to 2010 was utilized to identify the number of prevalent and incident cases of PM/DM. The electronic data entry rate was used to establish the total number of registered cases.

RESULTS

The estimated total number of patients with PM/DM and the prevalence rate in Japan in 2010 were 17,000 and 13.2 per 100,000 population, respectively. The prevalence of PM/DM ranged from 10 to 13 per 100,000 population with a trend toward increasing over time. The incidence of PM/DM was estimated within the range 10-13 per 1,000,000 person-years, except for 2003.

CONCLUSIONS

We report the prevalence and incidence of PM/DM recently in Japan for the first time at the nationwide population level. Because the prevalence seems to be increasing recently, continued monitoring of these epidemiologic features is required.

摘要

目的

估算日本多发性肌炎/皮肌炎(PM/DM)患者的数量以及该病的患病率和发病率。

方法

利用2003年至2010年全国难治性疾病登记系统中的电子数据库,确定PM/DM的现患病例数和新发病例数。采用电子数据录入率来确定登记病例的总数。

结果

2010年日本PM/DM患者的估计总数和患病率分别为17,000例和每10万人中13.2例。PM/DM的患病率为每10万人中10至13例,且有随时间增加的趋势。除2003年外,PM/DM的发病率估计在每100万人年10 - 13例的范围内。

结论

我们首次在全国人口水平上报告了日本近期PM/DM的患病率和发病率。由于患病率近期似乎在上升,因此需要持续监测这些流行病学特征。

相似文献

1
Prevalence and incidence of polymyositis and dermatomyositis in Japan.日本多发性肌炎和皮肌炎的患病率与发病率。
Mod Rheumatol. 2014 May;24(3):477-80. doi: 10.3109/14397595.2013.844308. Epub 2013 Oct 21.
2
Epidemiologic analysis of the clinical features of Japanese patients with polymyositis and dermatomyositis.日本多发性肌炎和皮肌炎患者临床特征的流行病学分析。
Mod Rheumatol. 2016;26(3):398-402. doi: 10.3109/14397595.2015.1091137. Epub 2015 Oct 27.
3
Incidence and prevalence of polymyositis and dermatomyositis in a health management organization in Buenos Aires.布宜诺斯艾利斯某健康管理组织中多发性肌炎和皮肌炎的发病率和患病率。
J Clin Rheumatol. 2013 Sep;19(6):303-7. doi: 10.1097/RHU.0b013e3182a21ba8.
4
Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort.成人多发性肌炎和皮肌炎的患病率和临床特征;来自一个大型且未选择的挪威队列的数据。
Ann Rheum Dis. 2015 Aug;74(8):1551-6. doi: 10.1136/annrheumdis-2013-205127. Epub 2014 Apr 2.
5
Increased risk of venous thromboembolism in patients with dermatomyositis/polymyositis: a nationwide cohort study.皮肌炎/多肌炎患者静脉血栓栓塞风险增加:一项全国性队列研究。
Thromb Res. 2014 Sep;134(3):622-6. doi: 10.1016/j.thromres.2014.06.021. Epub 2014 Jul 6.
6
Increased osteoporosis risk in dermatomyositis or polymyositis independent of the treatments: a population-based cohort study with propensity score.皮肌炎或多发性肌炎患者骨质疏松风险增加,与治疗无关:一项基于倾向评分的人群队列研究
Endocrine. 2016 Apr;52(1):86-92. doi: 10.1007/s12020-015-0756-x. Epub 2015 Oct 1.
7
Incidence and Prevalence of Idiopathic Inflammatory Myopathies in Korea: a Nationwide Population-based Study.韩国特发性炎性肌病的发病率和患病率:一项全国范围内基于人群的研究。
J Korean Med Sci. 2019 Feb 8;34(8):e55. doi: 10.3346/jkms.2019.34.e55. eCollection 2019 Mar 4.
8
Age at onset and gender distribution of systemic lupus erythematosus, polymyositis/dermatomyositis, and systemic sclerosis in Japan.在日本,红斑狼疮、多发性肌炎/皮肌炎和系统性硬化症的发病年龄和性别分布。
Mod Rheumatol. 2013 Jul;23(4):759-64. doi: 10.1007/s10165-012-0733-7. Epub 2012 Aug 19.
9
Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study.台湾地区皮肌炎和多发性肌炎的发病、癌症风险和死亡率:一项全国性人群研究。
Br J Dermatol. 2011 Dec;165(6):1273-9. doi: 10.1111/j.1365-2133.2011.10595.x. Epub 2011 Nov 3.
10
Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis.136 例日本皮肌炎、多发性肌炎和临床无肌病性皮肌炎患者恶性肿瘤的发病情况及预测因素。
Mod Rheumatol. 2011 Apr;21(2):178-83. doi: 10.1007/s10165-010-0362-y. Epub 2010 Oct 5.

引用本文的文献

1
Cancer and pulmonary fibrosis risks in patients with dermatomyositis and polymyositis: A retrospective cohort study.皮肌炎和多发性肌炎患者的癌症及肺纤维化风险:一项回顾性队列研究。
Heliyon. 2024 Jul 2;10(13):e33883. doi: 10.1016/j.heliyon.2024.e33883. eCollection 2024 Jul 15.
2
Unusual Manifestation of Dermatomyositis: Exacerbation of Hypertriglyceridemia.皮肌炎的不寻常表现:高甘油三酯血症加重
Cureus. 2023 Dec 27;15(12):e51149. doi: 10.7759/cureus.51149. eCollection 2023 Dec.
3
Characteristics and risk of interstitial lung disease in dermatomyositis and polymyositis: a retrospective cohort study in Japan.
特发性炎性肌病相关间质性肺病的特征与风险:日本一项回顾性队列研究。
Sci Rep. 2023 Oct 11;13(1):17172. doi: 10.1038/s41598-023-44092-9.
4
Epidemiology of the idiopathic inflammatory myopathies.特发性炎症性肌病的流行病学
Nat Rev Rheumatol. 2023 Nov;19(11):695-712. doi: 10.1038/s41584-023-01033-0. Epub 2023 Oct 6.
5
Phase 3, multicentre, randomised, double-blind, placebo-controlled, parallel-group study of ustekinumab in Japanese patients with active polymyositis and dermatomyositis who have not adequately responded to one or more standard-of-care treatments.一项针对未充分应答一种或多种标准治疗的活动性多发性肌炎和皮肌炎的日本患者的乌司奴单抗的 3 期、多中心、随机、双盲、安慰剂对照、平行组研究。
RMD Open. 2023 Aug;9(3). doi: 10.1136/rmdopen-2023-003268.
6
Cardiac involvement in polymyositis and dermatomyositis: diagnostic approaches.多发性肌炎和皮肌炎的心脏受累:诊断方法
Reumatologia. 2023;61(3):202-212. doi: 10.5114/reum/168362. Epub 2023 Jul 2.
7
Low serum level of citrullinated histone H3 in patients with dermatomyositis.皮肌炎患者血清中瓜氨酸化组蛋白 H3 水平降低。
J Clin Lab Anal. 2023 Mar;37(6):e24876. doi: 10.1002/jcla.24876. Epub 2023 Apr 1.
8
Myositis in Germany: epidemiological insights over 15 years from 2005 to 2019.德国的肌炎:2005年至2019年15年间的流行病学见解。
Neurol Res Pract. 2022 Dec 29;4(1):62. doi: 10.1186/s42466-022-00226-4.
9
Prevalence and incidence of neuromuscular conditions in the UK between 2000 and 2019: A retrospective study using primary care data.2000 年至 2019 年期间英国神经肌肉疾病的患病率和发病率:一项使用初级保健数据的回顾性研究。
PLoS One. 2021 Dec 31;16(12):e0261983. doi: 10.1371/journal.pone.0261983. eCollection 2021.
10
Disease burden and treatment sequence of polymyositis and dermatomyositis patients in Japan: a real-world evidence study.日本多发性肌炎和皮肌炎患者的疾病负担和治疗顺序:一项真实世界证据研究。
Clin Rheumatol. 2022 Mar;41(3):741-755. doi: 10.1007/s10067-021-05939-6. Epub 2021 Oct 22.